Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-07-03FDA Approved: BENICAR HCT — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Benicar HCT (olmesartan medoxomil–hydrochlorothiazide) from Cosette Pharmaceuticals, Inc., indic…
-
CLINICAL_TRIALS trial_result · 2013-06-27Clinical Trial Update: Influence of Catheter-based Renal Denervation in Diseases With Increased Sympathetic Activity [Phase 1, Phase 2]
This clinical trial update reports on catheter-based renal denervation for diseases with heightened sympathetic activity, spanning Phase 1 a…
-
CLINICAL_TRIALS research · 2013-06-27Clinical Trial Update: Observation Study of the Medication Switch at Patients Treated With Sitaxentan to a Regime Without Sitaxentan
An observational study update on switching patients from Sitaxentan to a regimen without Sitaxentan.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Exercise Training and Plasma Lipoproteins in Man [Phase 3]
Phase 3 trial evaluating the effect of exercise training on plasma lipoproteins in individuals with cardiovascular disease; the study status…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fasting Conditions [Phase 1]
This document reports the completion of a Phase 1 bioequivalence study evaluating metoprolol succinate extended-release tablets 200 mg under…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fed Conditions [Phase 1]
This Phase 1 trial evaluated bioequivalence of metoprolol succinate extended-release 200 mg under fed conditions and has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Efficacy and Safety of CKD-828 to Stage 2 Hypertension [Phase 3]
Phase 3 trial assessing CKD-828 for stage 2 hypertension has completed. The update reports on the efficacy and safety findings from the stud…
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Safety Study of Subcutaneously Administered PL-3994 in Subjects With Controlled Hypertension [Phase 2]
Phase 2 safety study of subcutaneously administered PL-3994 in adults with controlled hypertension completed; results were posted in 2013.
-
CLINICAL_TRIALS research · 2013-06-21Clinical Trial Update: Obstructive Sleep Apnea (OSA), Hypertension , β1 Subunit of Maxi-k+ Channel and Cardiovascular Risk
A completed clinical trial examining the relationship between obstructive sleep apnea and hypertension in the context of the β1 subunit of M…
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans [Phase 4]
Phase 4 study assessing the effect of a PPAR-alpha agonist on cytochrome P450 monooxygenase activity in hypertensive patients; results were …
-
CLINICAL_TRIALS trial_result · 2013-06-13Clinical Trial Update: Vitamin D and Omega-3 Inhibit Metabolic Syndrome [Phase 3]
Phase 3 trial update suggests Vitamin D and Omega-3 may inhibit metabolic syndrome components. The results come from a completed Phase 3 stu…
-
FDA approval · 2013-06-13FDA Approved: CLONIDINE HYDROCHLORIDE — Original Application (Method Pharmaceuticals, LLC)
The FDA approved the original ANDA for clonidine hydrochloride tablets from Method Pharmaceuticals, LLC, establishing a generic version of c…
-
FDA approval · 2013-06-12FDA Approved: ALDACTONE — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Aldactone (spironolactone) from Pfizer. The approval updates the drug’s labeling.
-
CLINICAL_TRIALS trial_result · 2013-06-12Clinical Trial Update: Impact of Catecholamine Spill-over on Outcome After RDN and EP Ablation
A clinical trial update investigating how catecholamine spill-over affects outcomes after renal denervation and electrophysiology ablation i…
-
FDA approval · 2013-06-11FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Losartan Potassium submitted by Aurobindo Pharma Limited.
-
CLINICAL_TRIALS research · 2013-06-11Clinical Trial Update: A Home-based Blood Pressure Monitoring Program to Promote Better Management of Hypertension [NA]
The document notes the completion of a Tehran University of Medical Sciences study evaluating a home-based blood pressure monitoring program…
-
FDA approval · 2013-06-10FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for losartan potassium by Alembic Pharmaceuticals Limited.
-
FDA approval · 2013-06-10FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
FDA approved a supplemental application for Losartan Potassium and Hydrochlorothiazide, confirming approval of a generic combination product…
-
CLINICAL_TRIALS research · 2013-06-07Clinical Trial Update: Resistant Hypertension Optimal Treatment [Phase 4]
An update on the Phase 4 Resistant Hypertension Optimal Treatment trial (NCT01643434) sponsored by Instituto do Coracao; the trial investiga…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension [Phase 3]
Phase 3 trial evaluating a fixed-dose combination of nebivolol and valsartan for stage 1–2 hypertension has completed. The update notes comp…
-
CLINICAL_TRIALS trial_result · 2013-05-31Clinical Trial Update: Feasibility Study of Renal Denervation for the Treatment of Resistant Hypertension [EARLY_Phase 1]
An early-phase 1 feasibility trial is evaluating renal denervation for resistant (uncontrolled) hypertension; the current status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Clinical trial update for Amlodipine/Atorvastatin (Caduet) under regulatory post-marketing commitments; study completed with results posted …
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Chronotherapy Versus Conventional BP Control to Correct Abnormal Circadian BP Pattern in Kidney Transplant Recipients [NA]
A completed Mayo Clinic trial compared chronotherapy (timing of antihypertensive treatment) versus conventional blood pressure control to co…
-
CLINICAL_TRIALS withdrawal · 2013-05-30Clinical Trial Update: Post Kidney Transplant Nocturnal Hypertension Prevalence and Management Study [NA]
The trial evaluating nocturnal hypertension in kidney transplant recipients was withdrawn from the registry.
-
FDA approval · 2013-05-28FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for the fixed-dose antihypertensive combination Losartan Potassium and Hydrochlorothiazide from …